Merlintrader
Latest company news, October 15, 2026: Nyxoah presented full 12-month ACCCESS data in complete concentric collapse patients at ISSS 2026: 77.2% AHI responder rate, 74.3% median AHI reduction (per-protocol), no device- or procedure-related serious adverse events. It also submitted a PMA supplement asking the FDA to extend Genio to these patients. $NYXH Details on our site. Not investment advice.
3
